Please login to the form below

Not currently logged in
Email:
Password:

Allergan opens Indian pharma R&D arm

US-headquartered Allergan has opened its first pharmaceutical R&D facility in India

According to local media reports, US-headquartered Allergan has opened its first pharmaceutical R&D facility in India.

The Allergan Pharmaceutical Development Centre India, which will make up part of Allergan's worldwide R&D operations, will focus on implementing global pharmaceutical R&D projects conducted in the region.

According to Scott M Whitcup, Allergan's worldwide executive vice-president of R&D, the centre would have 15 clinical research and data management personnel at the start of operations and could double within two years.

Whitcup said that Allergan's estimated investment for the new centre at USD 3m to USD 5m over the next few years. He added that R&D activities at the centre would initially focus on therapies in areas such as inflammatory and infective conditions of the eye, movement disorders and urological indications.

The centre is Allergan's third largest outside of the US. The company also has Allergan India, which manages the commercial side of Allergan's business there.

8th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics